Valsad - (+91) 6356399001/02/03
Daheradun - (+91) 7060105766, 9193763000/4000/5000
With an asset of more than 500 qualified employees and World Standard Development And Manufacturing Facilities in Dehradun, Valsad with an expertise For a range of formulations from tablets,capsules , Trans-dermal drug delivery dosage form, Sidmak India is poised for being among the fast growing pharmaceutical companies.
Pioneering efforts of Sidmak India in providing Quality Healthcare Products Developed And Manufactured from world- class state-of-the-art facilities.
The company has built new state of the art Development and Manufacturing facilities with systems and controls in compliance with Various Regulatory Agencies in the World including US cGMP. and has been offering formulation development services to US customers. Products developed for US customers are manufactured by Sidmak India and marketed by US customers with a profit share model.
Dehradun facility also offers contract manufacturing service for major Indian companies as well. Quality systems at Dehradun facility meets and exceeds US cGMP requirements ,Schedule M And WHO.
Sidmak-India makes strategic alliances with large, medium and small drug companies.
Strategic partners market products after Sidmak India develops, gets approval and manufactures the products.
Having a vision to provide Quality healthcare to humanity and with special focus on essential and difficult to make medicine, Sidmak India, with its domestic presence spanning more than two decades has ambitious growth plans for catering to the global healthcare market.
We value achievement of objectives and consistently strive towards our Vision, with perseverance.
We value knowledge such that it empowers our people to find innovative solutions to manage change.
We respect all our stakeholders.
Speciality Products : These products are complex in nature either by its inherent bio availability issues or formulation patent protection. A dozen or so companies have track record in successfully developing such products using non infringing technology. The founders of Sidmak India has had great success with this approach in US Sidmak. All products developed for USA customers are available to Sidmak India for markets other than USA, Canada and Mexico. The company intends to create strategic alliances for marketing these products in UK, Germany, France and other ROW markets.
Commodities: These products are rather simple formulations and after expiration of basic molecule patent, have no further protection. More than 100 companies worldwide can easily develop these products for USA.